Dr. Daud is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Divisasero Street
San Francisco, CA 94143Phone+1 415-353-7392
Education & Training
Government Medical College NagpurClass of 1987
Certifications & Licensure
CA State Medical License 2008 - 2026
FL State Medical License 2001 - 2010
NY State Medical License 1997 - 2003
Publications & Presentations
PubMed
- 1363 citationsAnti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trialCaroline Robert, Antoni Ribas, Jedd D. Wolchok, F. Stephen Hodi, Omid Hamid
Lancet. 2014-09-20 - 4127 citationsPembrolizumab versus Ipilimumab in Advanced MelanomaCaroline Robert, Jacob Schachter, Georgina V. Long, Ana Arance, Jean-Jacques Grob
The New England Journal of Medicine. 2015-06-24 - 786 citationsAssociation of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced MelanomaAntoni Ribas, Omid Hamid, Adil Daud, F. Stephen Hodi, Jedd D. Wolchok
JAMA. 2016-04-19
Journal Articles
- A Natural Killer–Dendritic Cell Axis Defines Checkpoint Therapy–Responsive Tumor MicroenvironmentsPatrick K Ha, William R Ryan, Nina Bhardwaj, Vincent Chan, Michael D Alvarado, Adil I Daud, Joy Hsu, Nature
Committees
- Member, SWOG melanoma 2006 - Present
Professional Memberships
- ASCOMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
